0001062993-22-002725.txt : 20220204
0001062993-22-002725.hdr.sgml : 20220204
20220204192558
ACCESSION NUMBER: 0001062993-22-002725
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220202
FILED AS OF DATE: 20220204
DATE AS OF CHANGE: 20220204
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: COBB CAROLE B
CENTRAL INDEX KEY: 0001225611
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39894
FILM NUMBER: 22595165
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GreenLight Biosciences Holdings, PBC
CENTRAL INDEX KEY: 0001822691
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 851914700
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 BOSTON AVENUE
STREET 2: SUITE 3100
CITY: MEDFORD
STATE: MA
ZIP: 02155
BUSINESS PHONE: (617) 616-8188
MAIL ADDRESS:
STREET 1: 200 BOSTON AVENUE
STREET 2: SUITE 3100
CITY: MEDFORD
STATE: MA
ZIP: 02155
FORMER COMPANY:
FORMER CONFORMED NAME: Environmental Impact Acquisition Corp
DATE OF NAME CHANGE: 20200826
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4
2022-02-02
0001822691
GreenLight Biosciences Holdings, PBC
GRNA
0001225611
COBB CAROLE B
C/O GREENLIGHT BIOSCIENCES HOLDINGS, PBC
200 BOSTON AVENUE, SUITE 3100
MEDFORD
MA
02155
0
1
0
0
Chief Operating Officer
Stock Option (Right to Buy)
0.35
2022-02-02
4
A
0
427752
A
2025-07-22
Common Stock
427752
427752
D
Stock Option (Right to Buy)
0.35
2022-02-02
4
A
0
43863
A
2026-10-21
Common Stock
43863
43863
D
Stock Option (Right to Buy)
0.33
2022-02-02
4
A
0
459264
A
2028-02-14
Common Stock
459264
459264
D
Stock Option (Right to Buy)
0.33
2022-02-02
4
A
0
187831
A
2028-09-13
Common Stock
187831
187831
D
Stock Option (Right to Buy)
0.50
2022-02-02
4
A
0
480560
A
2029-12-29
Common Stock
480560
480560
D
Stock Option (Right to Buy)
0.50
2022-02-02
4
A
0
26987
A
2029-12-29
Common Stock
26987
26987
D
Stock Option (Right to Buy)
0.98
2022-02-02
4
A
0
326144
A
2030-12-01
Common Stock
326144
326144
D
25% of the shares underlying the option vested or shall vest on July 23, 2016, and the remainder of the shares vested or shall vest in 48 equal monthly installments thereafter, starting August 23, 2016.
This option was issued pursuant to the terms of a business combination agreement involving the Issuer and GreenLight Biosciences, Inc. in exchange for a comparable option previously issued by such company.
20% of the shares underlying the option vested or shall vest on October 21, 2017, and the remainder of the shares vested or shall vest in 48 equal monthly installments thereafter, starting November 21, 2017.
20% of the shares underlying the option vested or shall vest on September 12, 2018, and the remainder of the shares vested or shall vest in 48 equal monthly installments thereafter, starting October 12, 2018.
20% of the shares underlying the option vested or shall vest on May 30, 2019, and the remainder of the shares vested or shall vest in 48 equal monthly installments thereafter, starting June 30, 2019.
20% of the shares underlying the option vested or shall vest on December 5, 2020 and the remainder of the shares vested or shall vest in 48 equal monthly installments thereafter, starting January 5, 2021.
25% of the shares underlying the option vested or shall vest on December 1, 2021 and the remainder of the shares vested or shall vest in 36 equal monthly installments thereafter, starting January 1, 2022.
/s/David Kennedy, Attorney-in-fact
2022-02-04